CSIMarket
 
Zai Lab Limited  (NASDAQ: ZLAB)
 

Zai Lab Limited's Suppliers Performance

ZLAB's Supply Chain




 
ZLAB Costs vs Sales of Suppliers Growth Zai Lab Limited's cost of sales deteriorated by -0.36 % year on year, relative to one quarter ago cost of sales fell by -38.5 % in Q1.

More on ZLAB Suppliers



Zai Lab Limited's cost of sales deteriorated by -0.36 % year on year, compare to one quarter ago cost of sales fell by -38.5 % in Q1.

More on ZLAB Suppliers




Zai Lab Limited's Comment on Supply Chain


The company utilizes suppliers including third-party licensors, raw material providers, and contract research organizations (CROs) to support its clinical trials. Licensed products include VYVGART and VYVGART Hytrulo from argenx, OPTUNE from NovoCure, QINLOCK from Deciphera, XACDURO from Innoviva, AUGTYRO from BMS, and TIVDAK from Pfizer. Raw materials for clinical trials are sourced from multiple suppliers in China and the United States without long-term supply contracts, and the company has not experienced material supply disruptions. CROs are engaged to assist with clinical trial operations. The company maintains a quality control system compliant with National Medical Products Administration (NMPA) regulations, with senior management overseeing quality policies and performance management.

Zai Lab Limited's Comment on Supply Chain


The company utilizes suppliers including third-party licensors, raw material providers, and contract research organizations (CROs) to support its clinical trials. Licensed products include VYVGART and VYVGART Hytrulo from argenx, OPTUNE from NovoCure, QINLOCK from Deciphera, XACDURO from Innoviva, AUGTYRO from BMS, and TIVDAK from Pfizer. Raw materials for clinical trials are sourced from multiple suppliers in China and the United States without long-term supply contracts, and the company has not experienced material supply disruptions. CROs are engaged to assist with clinical trial operations. The company maintains a quality control system compliant with National Medical Products Administration (NMPA) regulations, with senior management overseeing quality policies and performance management.







ZLAB's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Zai Lab Limited 2,801.70 453.28 -178.12 1,784
SUBTOTAL 0.00 0.00 0.00 -


Sources: Zai Lab Limited's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Zai Lab Limited’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.